Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693007016 | Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3693008014 | Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4540001000052118 | klindamycin (som klindamycinfosfat) 10 milligram/milliliter, kutan lösning | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Has manufactured dose form | Cutaneous solution | true | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Is a | klindamycin för lokalt bruk | false | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | har nämnarvärde som visar koncentrationsstyrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | räkning av bas i aktiv ingrediens | 1 (qualifier value) | false | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Has precise active ingredient | Clindamycin phosphate | true | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Has basis of strength substance (attribute) | Clindamycin (substance) | true | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | har täljarvärde för koncentrationsstyrka | 10 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Is a | Product containing only clindamycin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Is a | Product manufactured as cutaneous dose form (product) | false | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | Is a | Product containing pyrrolidine (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR